Ken Fisher Lantheus Holdings, Inc. Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 156,797 shares of LNTH stock, worth $16.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,797

Previous 158,375 1.0%

Holding current value

$16.6 Million

Previous $9.86 Million 27.72%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $92,896 - $131,052	-1,578 Reduced 1.0%	156,797 $12.6 Million
Q1 2024 May 09, 2024	SELL	$51.07 - $68.26 $6,588 - $8,805	-129 Reduced 0.08%	158,375 $9.86 Million
Q4 2023 Mar 05, 2024	BUY	$55.6 - $77.89 $7,506 - $10,515	135 Added 0.09%	158,504 $9.83 Million
Q4 2023 Feb 06, 2024	SELL	$55.6 - $77.89 $189,874 - $265,994	-3,415 Reduced 2.11%	158,369 $9.82 Million
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $5.47 Million - $8.24 Million	-90,785 Reduced 35.94%	161,784 $11.2 Million
Q2 2023 Dec 12, 2023	BUY	$82.41 - $99.65 $7.48 Million - $9.05 Million	90,785 Added 56.11%	252,569 $21.2 Million
Q2 2023 Aug 08, 2023	SELL	$82.41 - $99.65 $5.72 Million - $6.92 Million	-69,463 Reduced 21.57%	252,569 $21.2 Million
Q1 2023 Dec 12, 2023	BUY	$47.76 - $82.86 $4.64 Million - $8.04 Million	97,064 Added 60.0%	258,848 $21.4 Million
Q1 2023 May 01, 2023	SELL	$47.76 - $82.86 $1.6 Million - $2.78 Million	-33,581 Reduced 9.44%	322,032 $26.6 Million
Q4 2022 Feb 03, 2023	SELL	$48.76 - $77.67 $1.67 Million - $2.66 Million	-34,185 Reduced 8.77%	355,613 $18.1 Million
Q3 2022 Nov 08, 2022	SELL	$61.42 - $86.29 $8.41 Million - $11.8 Million	-136,918 Reduced 25.99%	389,798 $27.4 Million
Q2 2022 Aug 09, 2022	SELL	$55.54 - $72.65 $364,286 - $476,511	-6,559 Reduced 1.23%	526,716 $34.8 Million
Q1 2022 May 05, 2022	BUY	$24.28 - $56.64 $204,291 - $476,568	8,414 Added 1.6%	533,275 $29.5 Million
Q4 2021 Feb 02, 2022	BUY	$22.54 - $30.44 $3.42 Million - $4.62 Million	151,826 Added 40.7%	524,861 $15.2 Million
Q3 2021 Oct 26, 2021	BUY	$24.23 - $28.59 $7.96 Million - $9.39 Million	328,365 Added 735.09%	373,035 $9.58 Million
Q2 2021 Jul 27, 2021	SELL	$19.51 - $27.64 $31,098 - $44,058	-1,594 Reduced 3.45%	44,670 $1.24 Million
Q1 2021 Apr 27, 2021	SELL	$13.77 - $21.66 $7,780 - $12,237	-565 Reduced 1.21%	46,264 $989,000
Q4 2020 Jan 29, 2021	SELL	$10.75 - $14.91 $90,235 - $125,154	-8,394 Reduced 15.2%	46,829 $632,000
Q3 2020 Nov 10, 2020	SELL	$11.98 - $16.34 $232,256 - $316,783	-19,387 Reduced 25.98%	55,223 $700,000
Q2 2020 Aug 07, 2020	BUY	$10.34 - $15.51 $110,224 - $165,336	10,660 Added 16.67%	74,610 $1.07 Million
Q1 2020 Apr 28, 2020	SELL	$9.11 - $20.05 $100,018 - $220,128	-10,979 Reduced 14.65%	63,950 $816,000
Q4 2019 Feb 12, 2020	BUY	$18.47 - $24.03 $12,171 - $15,835	659 Added 0.89%	74,929 $1.54 Million
Q2 2019 Jul 30, 2019	BUY	$23.33 - $28.3 $186,546 - $226,286	7,996 Added 12.07%	74,270 $2.1 Million
Q4 2018 Jan 25, 2019	SELL	$12.68 - $19.01 $4,742 - $7,109	-374 Reduced 0.56%	66,274 $1.04 Million
Q3 2018 Oct 24, 2018	SELL	$13.1 - $16.35 $437,671 - $546,253	-33,410 Reduced 33.39%	66,648 $996,000
Q2 2018 Jul 09, 2018	SELL	$13.65 - $18.7 $269,382 - $369,044	-19,735 Reduced 16.47%	100,058 $1.46 Million
Q1 2018 May 11, 2018	SELL	$14.85 - $24.3 $746,687 - $1.22 Million	-50,282 Reduced 29.56%	119,793 $1.91 Million
Q1 2018 Apr 19, 2018	BUY	$14.85 - $24.3 $773,714 - $1.27 Million	52,102 Added 44.16%	170,075 $2.7 Million
Q4 2017 Jan 24, 2018	BUY	$17.4 - $23.4 $294,582 - $396,162	16,930 Added 16.76%	117,973 $2.41 Million
Q3 2017 Oct 17, 2017	BUY	$15.5 - $19.15 $1.57 Million - $1.93 Million	101,043	101,043 $1.8 Million

Others Institutions Holding LNTH

# of Institutions

495

Shares Held

67.2M

Call Options Held

1.19M

Put Options Held

829K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account